Carrie C Lubitz

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. doi Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms
    Carrie C Lubitz
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Thyroid 20:25-31. 2010
  2. doi Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism
    Carrie C Lubitz
    Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
    Surgery 148:1129-37; discussion 1137-8. 2010
  3. doi Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients
    Carrie C Lubitz
    From the Departments of Surgery C C L, K P E and Radiology G S G, Massachusetts General Hospital, Boston Department of Radiology, Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA C C L, K P E, C J, G S G Department of Health Policy and Management, Harvard T H Chan School of Public Health, Boston, MA S S, G S G, M C W, T A G Schwerpunkt Endokrinologie, Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universität München, Munchen, Germany H E K, M R and Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA T A G
    Circ Cardiovasc Qual Outcomes 8:621-30. 2015
  4. doi Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma
    Carrie C Lubitz
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts Electronic address
    J Mol Diagn 18:100-8. 2016
  5. pmc Preoperative localization strategies for primary hyperparathyroidism: an economic analysis
    Carrie C Lubitz
    Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 19:4202-9. 2012
  6. pmc Diagnostic yield of nondiagnostic thyroid nodules is not altered by timing of repeat biopsy
    Carrie C Lubitz
    Department of Surgery Endocrine Surgery Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Thyroid 22:590-4. 2012
  7. doi Surgery for Graves' disease: a 25-year perspective
    Roy Phitayakorn
    Thyroid Cancer Research Laboratory, Endocrine Surgery Unit, The Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, Wang ACC 460, Boston, MA 02115, USA
    Am J Surg 206:669-73. 2013
  8. pmc BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence
    Jason D Prescott
    Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 2696, USA
    Surgery 152:984-90. 2012
  9. pmc Management of thyroid nodules with atypical cytology on fine-needle aspiration biopsy
    Sushruta S Nagarkatti
    Thyroid Cancer Laboratory, Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 20:60-5. 2013
  10. doi Identification of borderline thyroid tumors by gene expression array analysis
    Nimmi Arora
    Department of Surgery, New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York 10065, USA
    Cancer 115:5421-31. 2009

Collaborators

Detail Information

Publications25

  1. doi Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms
    Carrie C Lubitz
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Thyroid 20:25-31. 2010
    ..The aim of this study was to determine predictive characteristics of follicular neoplasms useful for clinical application...
  2. doi Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism
    Carrie C Lubitz
    Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
    Surgery 148:1129-37; discussion 1137-8. 2010
    ..We assessed the role of 4D-CT in patients with inconclusive preoperative ultrasound and sestamibi localization studies...
  3. doi Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients
    Carrie C Lubitz
    From the Departments of Surgery C C L, K P E and Radiology G S G, Massachusetts General Hospital, Boston Department of Radiology, Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA C C L, K P E, C J, G S G Department of Health Policy and Management, Harvard T H Chan School of Public Health, Boston, MA S S, G S G, M C W, T A G Schwerpunkt Endokrinologie, Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universität München, Munchen, Germany H E K, M R and Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA T A G
    Circ Cardiovasc Qual Outcomes 8:621-30. 2015
    ..We aim to assess if the long-term cardiovascular benefits of identifying and treating surgically correctable PA outweigh the upfront increased costs in patients at the time patients are diagnosed with resistant hypertension (RH)...
  4. doi Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma
    Carrie C Lubitz
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts Electronic address
    J Mol Diagn 18:100-8. 2016
    ..This blood assay is feasible and has potential as a biomarker for prognosis, surveillance, clinical decision making, and assessment of treatment response to BRAF-targeted therapies. ..
  5. pmc Preoperative localization strategies for primary hyperparathyroidism: an economic analysis
    Carrie C Lubitz
    Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 19:4202-9. 2012
    ..Strategies for localizing parathyroid pathology preoperatively vary in cost and accuracy. Our purpose was to compute and compare comprehensive costs associated with common localization strategies...
  6. pmc Diagnostic yield of nondiagnostic thyroid nodules is not altered by timing of repeat biopsy
    Carrie C Lubitz
    Department of Surgery Endocrine Surgery Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Thyroid 22:590-4. 2012
    ..Our aims were to assess which factors influenced their clinical management and to determine if the timing of the repeat FNAB affects the diagnostic yield...
  7. doi Surgery for Graves' disease: a 25-year perspective
    Roy Phitayakorn
    Thyroid Cancer Research Laboratory, Endocrine Surgery Unit, The Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, Wang ACC 460, Boston, MA 02115, USA
    Am J Surg 206:669-73. 2013
    ..Optimal treatment of Graves' disease (GD) remains controversial. The authors retrospectively reviewed the surgical cases of GD at a single academic tertiary center...
  8. pmc BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence
    Jason D Prescott
    Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 2696, USA
    Surgery 152:984-90. 2012
    ..No current risk classification system incorporates BRAF mutational status. Here, we assess the incremental value of BRAF mutational status in predicting PTC recurrence relative to existing recurrence risk algorithms...
  9. pmc Management of thyroid nodules with atypical cytology on fine-needle aspiration biopsy
    Sushruta S Nagarkatti
    Thyroid Cancer Laboratory, Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 20:60-5. 2013
    ..We sought to assess the characteristics and treatment of patients with an AUS/FLUS FNAB at our institution. Additionally, we evaluated the utility of the recommended 3-month timing of repeat FNAB...
  10. doi Identification of borderline thyroid tumors by gene expression array analysis
    Nimmi Arora
    Department of Surgery, New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York 10065, USA
    Cancer 115:5421-31. 2009
    ..A subset of follicular lesions of the thyroid is encapsulated similar to follicular adenomas but with partial nuclear features suggestive of papillary thyroid carcinoma (PTC), raising the possibility of biologically borderline tumors...
  11. pmc Annual financial impact of well-differentiated thyroid cancer care in the United States
    Carrie C Lubitz
    Harvard Medical School, Boston, Massachusetts Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts
    Cancer 120:1345-52. 2014
    ..Prior analyses of the aggregate health care costs attributable to WDTC in the United States have not been reported...
  12. pmc Recalcitrant hypocalcemia after thyroidectomy in patients with previous Roux-en-Y gastric bypass
    Travis J McKenzie
    Massachusetts General Hospital, Department of Surgery, Wang Ambulatory Care Center, Boston, MA Electronic address
    Surgery 154:1300-6; discussion 1306. 2013
    ..This complication is poorly described and there is no current consensus on optimal management in this unique population...
  13. doi Surgical drains can be safely avoided in lateral neck dissections for papillary thyroid cancer
    Michal Mekel
    Endocrine Surgery Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Am J Surg 199:485-90. 2010
    ..Drains are widely used in lateral neck dissections (LNDs). Our objective was to compare outcomes of LNDs for papillary thyroid cancer (PTC) with and without drains...
  14. pmc Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma
    Dana T Yip
    Departments of Surgery, Pathology, and Thyroid Unit, Massachusetts General Hospital, Boston, MA 02114, USA
    Surgery 150:1168-77. 2011
    ..We hypothesized that preoperative serum levels of calcitonin and carcinoembryonic antigen (CEA) correlate with extent of disease and postoperative levels reflect the extent of operation performed...
  15. ncbi Molecular analysis of minimally invasive follicular carcinomas by gene profiling
    Carrie C Lubitz
    Department of Surgery, Weill Medical College of Cornell University, New York, NY 10021, USA
    Surgery 138:1042-8; discussion 1048-9. 2005
    ..These studies were conducted to determine if molecular profiling can enhance our understanding of MIFTC and to perhaps offer a better classification schema...
  16. doi Should specific patient clinical characteristics discourage adrenal surgeons from performing laparoscopic transperitoneal adrenalectomy?
    Konstantinos P Economopoulos
    Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA
    Surgery 159:240-9. 2016
    ..We sought to determine whether LTA in these clinical situations is associated with worse outcomes...
  17. doi Primary hyperparathyroidism after Roux-en-Y gastric bypass
    Yufei Chen
    Massachusetts General Hospital, GRB 425, 55 Fruit Street, Boston, MA, 02114, USA
    Obes Surg 25:700-4. 2015
    ..The diagnosis can be difficult, as secondary hyperparathyroidism (SHPT) commonly occurs in patients after RYGBP due to calcium malabsorption and vitamin D deficiency...
  18. pmc Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions
    Carrie C Lubitz
    Department of Surgery, Weill Cornell Medical College, Room A 983, 510 East 70th St, New York, NY 10021, USA
    J Mol Diagn 8:490-8; quiz 528. 2006
    ..These results illustrate that microarray analysis of FNA is feasible and has the potential to improve the accuracy of FNA in categorizing benign from malignant lesions beyond routine cytological evaluation...
  19. ncbi Gene expression profiling of thyroid tumors--clinical applicability
    Carrie C Lubitz
    Department of Surgery, Weill Medical College of Cornell University, New York, NY 10021, USA
    Nat Clin Pract Endocrinol Metab 2:472-3. 2006
  20. ncbi The differentiation of benign and malignant thyroid nodules
    Carrie C Lubitz
    Department of Surgery, New York Presbyterian Hospital, USA
    Adv Surg 39:355-77. 2005
  21. doi BRAF(V600E) Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis
    Yufei Chen
    1 Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts
    Thyroid 26:248-55. 2016
    ..The BRAF(V600E) mutation has been associated with recurrent disease in larger tumors. However, its correlation in papillary thyroid microcarcinoma (PTMC) is not clear in individual series...
  22. pmc Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile
    Carrie C Lubitz
    1 Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
    Thyroid 24:958-65. 2014
    ..Herein, we describe the clinical course, pathologic features, and mutational profile of patients at our institution with HVPTC...
  23. doi How to interpret thyroid fine-needle aspiration biopsy reports: a guide for the busy radiologist in the era of the Bethesda Classification System
    Manish Dhyani
    1 Department of Radiology, Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, White 270, Boston, MA 02114
    AJR Am J Roentgenol 201:1335-9. 2013
    ..This article reviews the Bethesda System, emphasizing the key facts necessary to understand thyroid biopsy results and effectively manage patients after FNAB...
  24. doi Surgeons and patients disagree on the potential consequences from hypoparathyroidism
    Nancy L Cho
    Department of Surgery, Brigham and Women s Hospital, Boston, Massachusetts
    Endocr Pract 20:427-46. 2014
    ..To test the hypothesis that surgeons and their patients underestimate the potential negative impact that permanent hypoparathyroidism has on quality of life (QOL)...
  25. ncbi Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling
    David J Finley
    Department of Surgery, Weill Medical College of Cornell University, New York, New York, USA
    Thyroid 15:562-8. 2005
    ..These studies were undertaken to determine whether benign follicular tumors could be subcategorized by molecular profiling...